Stay updated on Sitravatinib in Hepatic Impairment Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib in Hepatic Impairment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib in Hepatic Impairment Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.4.0 to v3.4.1; core study details and content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:58:04.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a Show glossary toggle and updated study record metadata with a new 'Last Update Submitted that Met QC Criteria' field, capitalization changes to 'No FEAR Act Data', and a version bump to v3.4.0 (from v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T21:40:32.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision label in the page footer updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:05:38.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Added a consolidated Locations section and removed state-specific location entries (California, Florida, Minnesota, Texas) as part of a revision, and removed the HHS Vulnerability Disclosure link.
    Difference
    0.6%
    Check dated 2025-12-23T21:28:22.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 with no changes to core page content or user-facing details.
    Difference
    0.1%
    Check dated 2025-11-25T10:38:13.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    A government funding status notice was removed from the page, eliminating updates about potential delays in information and site operations. Core study details and eligibility criteria remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T06:55:13.000Z thumbnail image

Stay in the know with updates to Sitravatinib in Hepatic Impairment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib in Hepatic Impairment Clinical Trial page.